Status:
COMPLETED
Evaluating a Novel Medication Device for Methadone Dosing
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Opioid-use Disorder
Eligibility:
All Genders
Phase:
NA
Brief Summary
This study will evaluate whether a commercially available, secure, electronic pill box is a feasible, acceptable, and satisfactory method to manage take-home dosing of methadone for both methadone cli...
Eligibility Criteria
Inclusion
- 18 years or older
- Receiving methadone for the treatment of opioid use disorder for at least 90 days and having been on the same methadone dose for at least 30 days
- Have previously received a take-home dose of methadone as part of routine care
- Be willing to comply with the study schedule
- Be a methadone patient in the clinic within which this study is being conducted
Exclusion
- Pregnancy
- Presence of an acute medical problems that requires immediate or intense medical management
- Presence of serious or unstable mental illness that interferes with study procedures
- Planning to leave methadone treatment within the next 12 weeks
- Being maintained on a dose of methadone that is less than 10mg or more than 100mg
- Currently receiving split doses of methadone as part of routine care
Key Trial Info
Start Date :
January 31 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 30 2020
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT03254043
Start Date
January 31 2018
End Date
March 30 2020
Last Update
September 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Addiction Treatment Services (ATS)
Baltimore, Maryland, United States, 21224